Intestinal Microbiota Can Predict Acute Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation
- PMID: 31299215
- DOI: 10.1016/j.bbmt.2019.07.006
Intestinal Microbiota Can Predict Acute Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation
Abstract
The intestinal microbiome plays an important role in the development of acute graft-versus-host disease (aGVHD). However, whether intestinal microbiota can predict the development of aGVHD has been reported only rarely. Here we conducted a prospective study of microbiota in 141 patients after allogeneic hematopoietic stem cell transplantation. We found lower microbiota diversity in the aGVHD group compared with the non-aGVHD group at day 0 and day 15 ± 1 (P = .018 and .009, respectively). Diversity was negatively associated with conditioning intensity (P = .017, day 0; P = .045, day 15) and β-lactam antibiotic administration (P = .004, day 15). Intensified conditioning and β-lactam antibiotics were associated with a lower regulatory T (Treg)/T helper 17 (Th17) cell ratio at day 15 (P = .030 and .047, respectively). At day 15, the levels of the inflammatory factors (tumor necrosis factor α, interleukin [IL]-6, IL-17A, IL-1β, and lipopolysaccharide) were higher in the intensified conditioning group compared with the standard group (P < .05). The accumulated intestinal microbiota (AIM) score was defined as microbiota diversity and gradient of the 4 bacterials (Lachnospiraceae, Peptostreptococcaceae, Erysipelotrichaceae, and Enterobacteriaceae) at day 15 post-transplantation. The AIM score was positively correlated with aGVHD grade (r = .481, P < .001), and the AIM score could be predictive of the development of aGVHD (grade II-IV aGVHD: area under the curve [AUC], .75, P < .001; grade III-IV aGVHD: AUC, .84, P < .001). These findings suggest that intestinal microbiota and conditioning might induce aGVHD by inflammatory factors and the Treg/Th17 balance. The constitution of the intestinal microbiota at neutrophil engraftment may predict the development of aGVHD.
Keywords: Acute graft-versus-host disease; Allogeneic hematopoietic stem cell transplantation; Intestinal microbiota; Microbiota diversity; Microbiota marker.
Copyright © 2019 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Intestinal Microbiota at Engraftment Influence Acute Graft-Versus-Host Disease via the Treg/Th17 Balance in Allo-HSCT Recipients.Front Immunol. 2018 Apr 24;9:669. doi: 10.3389/fimmu.2018.00669. eCollection 2018. Front Immunol. 2018. PMID: 29740427 Free PMC article.
-
A gut microbiota score predicting acute graft-versus-host disease following myeloablative allogeneic hematopoietic stem cell transplantation.Am J Transplant. 2020 Apr;20(4):1014-1027. doi: 10.1111/ajt.15654. Epub 2019 Dec 12. Am J Transplant. 2020. PMID: 31605563 Free PMC article.
-
Vedolizumab for prevention of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.Blood Adv. 2019 Dec 10;3(23):4136-4146. doi: 10.1182/bloodadvances.2019000893. Blood Adv. 2019. PMID: 31821456 Free PMC article. Clinical Trial.
-
Emerging Influence of the Intestinal Microbiota during Allogeneic Hematopoietic Cell Transplantation: Control the Gut and the Body Will Follow.Biol Blood Marrow Transplant. 2015 Aug;21(8):1360-6. doi: 10.1016/j.bbmt.2015.02.016. Epub 2015 Feb 21. Biol Blood Marrow Transplant. 2015. PMID: 25708215 Review.
-
Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.Dan Med Bull. 2007 May;54(2):112-39. Dan Med Bull. 2007. PMID: 17521527 Review.
Cited by
-
Intestinal Microbiome in Hematopoietic Stem Cell Transplantation For Autoimmune Diseases: Considerations and Perspectives on Behalf of Autoimmune Diseases Working Party (ADWP) of the EBMT.Front Oncol. 2021 Oct 22;11:722436. doi: 10.3389/fonc.2021.722436. eCollection 2021. Front Oncol. 2021. PMID: 34745944 Free PMC article.
-
The association of intestinal microbiota diversity and outcomes of allogeneic hematopoietic cell transplantation: a systematic review and meta-analysis.Ann Hematol. 2023 Dec;102(12):3555-3566. doi: 10.1007/s00277-023-05460-7. Epub 2023 Sep 28. Ann Hematol. 2023. PMID: 37770617
-
Intestinal microbiota score could predict survival following allogeneic hematopoietic stem cell transplantation.Ann Hematol. 2022 Jun;101(6):1283-1294. doi: 10.1007/s00277-022-04817-8. Epub 2022 Mar 25. Ann Hematol. 2022. PMID: 35332375 Free PMC article.
-
Early intestinal microbial features are associated with CD4 T-cell recovery after allogeneic hematopoietic transplant.Blood. 2022 May 5;139(18):2758-2769. doi: 10.1182/blood.2021014255. Blood. 2022. PMID: 35061893 Free PMC article.
-
Perspectives for the Use of Fucoidans in Clinical Oncology.Int J Mol Sci. 2022 Oct 5;23(19):11821. doi: 10.3390/ijms231911821. Int J Mol Sci. 2022. PMID: 36233121 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources